The department has grappled with an officer's death and scrutiny around another's use of force in the past year.
A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...
Oral cancer -- also known as head and neck squamous cell carcinoma -- affects the mouth, throat, nose, sinuses and voice box. The cancer takes root in epithelial cells, the top layer of cells lining ...
Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...
Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...
A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.
1d
News Medical on MSNScottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancerRegeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Combination treatment with ibrilatazar and chemotherapy has demonstrated “promising efficacy and safety” in patients with advanced squamous non-small cell lung cancer (NSCLC), according to researchers ...
UC San Diego researchers have identified the molecular and cellular mechanisms that transform healthy stem cells into oral cancer at the earliest stages of the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results